EGM
ACET icon

Engineers Gate Manager’s Adicet Bio ACET Stock Holding History

Engineers Gate Manager’s Portfolio ACET Stock Details ACET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,562
Closed -$30.2K – 2074
2024
Q2 		$30.2K Sell
1,562
-49
-3% -$1.31K ﹤0.01% 1837
2024
Q1 		$60.6K Buy
+1,611
New +$66.6K ﹤0.01% 1794
2023
Q3 		– Sell
-2,963
Closed -$115K – 1746
2023
Q2 		$115K Buy
2,963
+1,609
+119% +$142K ﹤0.01% 1554
2023
Q1 		$125K Sell
1,354
-1,380
-50% -$173K 0.01% 1491
2022
Q4 		$391K Buy
+2,734
New +$682K 0.02% 1048
2022
Q3 		– Sell
-1,048
Closed -$245K – 1562
2022
Q2 		$245K Buy
+1,048
New +$230K 0.01% 1533
2022
Q1 		– Sell
-856
Closed -$239K – 1793
2021
Q4 		$239K Buy
+856
New +$147K 0.01% 1542
2020
Q3 		– Sell
-1,102
Closed -$265K – 1631
2020
Q2 		$265K Buy
+1,102
New +$217K 0.01% 1277
2020
Q1 		– Sell
-221
Closed -$37K – 1527
2019
Q4 		$37K Buy
221
+50
+29% +$25.3K ﹤0.01% 1575
2019
Q3 		$169K Buy
+171
New +$191K 0.01% 1238

Other funds holding ACET

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Engineers Gate Manager's ACET Position: Q3 2024 in Review

Engineers Gate Manager sold out of Adicet Bio (ACET) in Q3 2024, closing a stake of 1,562 shares — an estimated $30.2K sold.

Engineers Gate Manager first reported a position in ACET in Q3 2019 and held it in 10 quarters. The position peaked at $391K in Q4 2022. 64 funds tracked by Wall St. Rank hold ACET as of Q3 2024.

  • Engineers Gate Manager reported no remaining Adicet Bio position as of Q3 2024 after selling out during the quarter.
  • Engineers Gate Manager sold 1,562 Adicet Bio shares in Q3 2024, an estimated $30.2K.
  • Engineers Gate Manager first reported a position in Adicet Bio in Q3 2019 and held it in 10 quarters.
  • Engineers Gate Manager's Adicet Bio position peaked at $391K in Q4 2022.
  • 64 funds tracked by Wall St. Rank held Adicet Bio as of Q3 2024.

Based on Engineers Gate Manager's 13F filing for Q3 2024, filed 14 Nov 2024.